These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 27304215)
1. Influence of Medical Representatives on Prescribing Practices in Mekelle, Northern Ethiopia. Workneh BD; Gebrehiwot MG; Bayo TA; Gidey MT; Belay YB; Tesfaye DM; Kassa TT PLoS One; 2016; 11(6):e0156795. PubMed ID: 27304215 [TBL] [Abstract][Full Text] [Related]
2. A survey of german physicians in private practice about contacts with pharmaceutical sales representatives. Lieb K; Brandtönies S Dtsch Arztebl Int; 2010 Jun; 107(22):392-8. PubMed ID: 20574555 [TBL] [Abstract][Full Text] [Related]
3. Physicians' perceptions of medical representative visits in Yemen: a qualitative study. Al-Areefi MA; Hassali MA; Ibrahim MI BMC Health Serv Res; 2013 Aug; 13():331. PubMed ID: 23962304 [TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples. Khazzaka M BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295 [TBL] [Abstract][Full Text] [Related]
5. The attitude and acceptability towards medical promotional tools and their influence on physicians' prescribing practices in Jordan and Iraq: a cross-sectional study. Ali KE; Naser AY; Al-Rousan R; Alwafi H; AbuAlhommos AK; Alsairafi ZK; Salawati EM; Samannodi M; Dairi MS BMC Health Serv Res; 2022 Jan; 22(1):105. PubMed ID: 35078461 [TBL] [Abstract][Full Text] [Related]
6. Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications. Fadare JO; Oshikoya KA; Ogunleye OO; Desalu OO; Ferrario A; Enwere OO; Adeoti A; Sunmonu TA; Massele A; Baker A; Godman B Hosp Pract (1995); 2018 Apr; 46(2):77-87. PubMed ID: 29426263 [TBL] [Abstract][Full Text] [Related]
7. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review. Fickweiler F; Fickweiler W; Urbach E BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287 [TBL] [Abstract][Full Text] [Related]
8. Patients' attitudes about gifts to physicians from pharmaceutical companies. Blake RL; Early EK J Am Board Fam Pract; 1995; 8(6):457-64. PubMed ID: 8585404 [TBL] [Abstract][Full Text] [Related]
9. Influence of pharmaceutical promotion on prescribers in Jordan. Altawalbeh SM; Ibrahim IA; Al-Shatnawi SF Int J Clin Pharm; 2020 Apr; 42(2):744-755. PubMed ID: 32140917 [TBL] [Abstract][Full Text] [Related]
10. A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers. Halperin EC; Hutchison P; Barrier RC Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1477-83. PubMed ID: 15275735 [TBL] [Abstract][Full Text] [Related]
11. Changes in Japanese physicians' relationships with the pharmaceutical industry between 2008 and 2021: A national survey. Saito S; Mukohara K; Shimomura K; Murotani K PLoS One; 2023; 18(6):e0286339. PubMed ID: 37262046 [TBL] [Abstract][Full Text] [Related]
12. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data. Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611 [TBL] [Abstract][Full Text] [Related]
13. Attitudes and relationship between physicians and the pharmaceutical industry in a public general hospital in Lima, Peru. De Ferrari A; Gentille C; Davalos L; Huayanay L; Malaga G PLoS One; 2014; 9(6):e100114. PubMed ID: 24978481 [TBL] [Abstract][Full Text] [Related]
14. Report: Interactions and conflicts of interests between prescribers and medical sales representatives (MSRs) regarding prescribing and drug promotion practices in Karachi, Pakistan. Naqvi AA; Zehra F; Khan N; Ahmad R; McGarry K Pak J Pharm Sci; 2019 Mar; 32(2):687-695. PubMed ID: 31081784 [TBL] [Abstract][Full Text] [Related]
15. Public perceptions of physician-pharmaceutical industry relationships and trust in physicians. Saito S; Mukohara K; Shimomura K; Murotani K PLoS One; 2023; 18(11):e0294854. PubMed ID: 38015917 [TBL] [Abstract][Full Text] [Related]
16. Extent of physician-pharmaceutical industry interactions in low- and middle-income countries: a systematic review. Fadlallah R; Alkhaled L; Brax H; Nasser M; Rajabbik MH; Nass H; Kahale LA; Akl EA Eur J Public Health; 2018 Apr; 28(2):224-230. PubMed ID: 29165586 [TBL] [Abstract][Full Text] [Related]
17. Japanese practicing physicians' relationships with pharmaceutical representatives: a national survey. Saito S; Mukohara K; Bito S PLoS One; 2010 Aug; 5(8):e12193. PubMed ID: 20730093 [TBL] [Abstract][Full Text] [Related]
18. Influence of pharmaceutical marketing mix strategies on physicians' prescribing behaviors in public and private hospitals, Dessie, Ethiopia: a mixed study design. Hailu AD; Workneh BD; Kahissay MH BMC Public Health; 2021 Jan; 21(1):65. PubMed ID: 33413248 [TBL] [Abstract][Full Text] [Related]
19. [Is it pertinent to investigate the relations between physicians and the drug industry]. Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930 [TBL] [Abstract][Full Text] [Related]